Myopathy Induced by HMG–CoA Reductase Inhibitors in Rabbits: A Pathological, Electrophysiological, and Biochemical Study
- 1 September 1998
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 152 (1) , 99-106
- https://doi.org/10.1006/taap.1998.8491
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effects of HMG-CoA reductase inhibitors on skeletal muscles of rabbitsZeitschrift für Die Gesamte Experimentelle Medizin, 1993
- HMG CoA reductase inhibitorsCurrent Opinion in Lipidology, 1992
- Cholesterol‐lowering agent myopathy (CLAM)Neurology, 1991
- Rhabdomyolysis with Simvastatin UseNephron, 1991
- Lovastatin decreases coenzyme Q levels in humans.Proceedings of the National Academy of Sciences, 1990
- The HMG CoA reductase inhibitorsCurrent Opinion in Lipidology, 1990
- Regulation of the mevalonate pathwayNature, 1990
- Rhabdomyolysis and Renal Injury With Lovastatin UsePublished by American Medical Association (AMA) ,1988
- Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac TransplantationNew England Journal of Medicine, 1988
- HISTOCHEMICAL METHODS FOR ACID PHOSPHATASE USING HEXAZONIUM PARAROSANILIN AS COUPLERJournal of Histochemistry & Cytochemistry, 1962